"This is a tremendous opportunity for HMHI to join a national collaborative effort to tackle 抑郁症 and related 心理健康 disorders,” 马克H. 医学博士，首席执行官 在HMHI. "Our acceptance into this leading-edge group will enable us to work more closely with other institutions that share our passion and commitment to developing better prevention and treatment options for the world's most disabling condition. By joining forces in this growing network of centers across the country, we can bring our expertise to a collaborative effort and accelerate the pace to eradicate this disease."
成立于2008年, NNDC works to harness network members' collective knowledge and resources to expedite scientific discovery and patient care for people with 情绪障碍. Membership includes many of the nation's top medical institutions, and acceptance involves a rigorous application process detailing high levels of expertise in clinical delivery, 研究, 和教育.
"We are thrilled to welcome HMHI into the NNDC," said NNDC President J. 雷蒙德·德保罗，医学博士. "Their approach to integrating mood disorder 研究, 培训, and treatment will add tremendous strength to our growing collaborative network. We look forward to collaborating with their faculty who have done excellent work and will bring unique opportunities to our national network. Working together with talented faculty at our other academic health centers, we can translate their insights to a nation much in need of 心理健康 care and healing."
HMHI, together with the broader University of Utah Health system, continues to expand the integration of 研究 with clinical care and 培训. This integrated approach has been in place since 2016 when University of Utah Health implemented universal 抑郁症 screening in primary care and specialty clinics. The program was developed to address 抑郁症 at the system level through improved screening and follow-up to improve patient outcomes.
"Mood disorders can be devastating and occur at any time in a person's life,” 布赖恩·米奇，博士，医学博士, associate professor 在HMHI. "HMHI 研究ers are conducting numerous studies to deepen understanding of 情绪障碍 through extensive brain imaging as well as studying the genetics behind 情绪障碍 and suicide. We are also working to develop new treatments for severe depressive disorders and gathering data needed to develop personalized treatment breakthroughs for children, 青少年, 和成人."
Most outpatient care for 情绪障碍 in the University of Utah Health system are treated in primary care clinics, and specialty care is provided at four HMHI outpatient behavioral health clinics. HMHI的 Treatment-Resistant Mood Disorder (TRMD) Clinic provides care to more than 500 patients annually. It is staffed by psychiatrists, 护士, and support staff uniquely trained to manage difficult-to-treat major depressive and bipolar 情绪障碍. This referral-based clinic is the only one in Utah to provide a full range of evidence-based treatment options for 情绪障碍. Inpatient and outpatient therapies include electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), vagus nerve stimulation (VNS), 静脉注射氯胺酮.
The TRMD clinic 在HMHI has evolved from a very small service started in the early 1990s managed by one person and has grown every year. As new treatments for 抑郁症 have evolved, the TRMD clinic has grown to add new treatments, 临床试验, 培训机会. 这家诊所最近扩大了, allowing clinicians and 研究ers to see twice as many patients and manage multiple treatment rooms simultaneously.
关于HMHI
HMHI is part of the world-renowned University of Utah Health system working to transform 心理健康 care and fulfill its mission to advance 心理健康 knowledge, 希望, 治愈一切. HMHI provides a continuum of services for patients across their lifespan, is a pioneering force in understanding the complex causes of psychiatric illness, and is devoted to 培训 the next generation of exceptional physicians, 护士, 社会工作者, and other 心理健康 professionals for the Mountain West.